1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screening
Kjellman, A. ; Akre, O. ; Gustafsson, O. ; Høyer-Hansen, G. ; Lilja, H. LU
; Norming, U.
; Piironen, T.
and Törnblom, M.
(2011)
In Journal of Internal Medicine
269(3).
p.299-305
- Contribution to journal › Article
- 2004
-
Mark
Lead time associated with screening for prostate cancer
Tornblom, M ; Eriksson, H ; Franzen, S ; Gustafsson, O ; Lilja, Hans LU
; Norming, U
and Hugosson, J
(2004)
In International Journal of Cancer
108(1).
p.122-129
- Contribution to journal › Article
- 2001
-
Mark
Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level
Tornblom, M ; Norming, U ; Becker, Charlotte LU ; Lilja, Hans LU
and Gustafsson, O
(2001)
In BJU International
87(7).
p.638-642
- Contribution to journal › Article
- 1999
-
Mark
Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL
Tornblom, M ; Norming, U ; Adolfsson, J ; Becker, Charlotte LU ; Abrahamsson, Per-Anders LU ; Lilja, Hans LU
and Gustafsson, O
(1999)
In Urology
53(5).
p.945-950
- Contribution to journal › Article